A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement

Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Eosinophilia* / diagnosis
  • Eosinophilia* / genetics
  • Humans
  • Imatinib Mesylate
  • Myeloproliferative Disorders* / diagnosis
  • Myeloproliferative Disorders* / genetics
  • Neoplasms*
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism
  • Receptor, Platelet-Derived Growth Factor alpha / genetics
  • Receptor, Platelet-Derived Growth Factor alpha / metabolism
  • mRNA Cleavage and Polyadenylation Factors / genetics

Substances

  • Imatinib Mesylate
  • mRNA Cleavage and Polyadenylation Factors
  • Oncogene Proteins, Fusion
  • Receptor, Platelet-Derived Growth Factor alpha